This Market Brief examines the pertinent regulatory issues affecting pharmaceutical companies operating in the US. It evaluates the current codes of practice and regulations affecting online direct-to-consumer (DTC) marketing and electronic records and signatures. Datamonitor recommends strategies for compliance with existing and forthcoming regulations. How can you benefit from this report? * Gain insight into the interpretation of 21 CFR Part 11 as it applies to electronic records and signatures in the clinical setting * Learn the characteristics of a functional electronic system and how to select a vendor * Create online DTC marketing strategies compliant with current regulations
